Protocol design and current status of CLIVIT: a randomized controlled multicenter relevance trial comparing clips versus ligatures in thyroid surgery by Seiler, CM et al.
BioMed  Central
Page 1 of 6
(page number not for citation purposes)
Trials
Open Access Study protocol
Protocol design and current status of CLIVIT: a randomized 
controlled multicenter relevance trial comparing clips versus 
ligatures in thyroid surgery
CM Seiler1,3, BE Fröhlich3, JA Veit1,3, E Gazyakan3, MN Wente1,3, 
C Wollermann2, A Deckert2, S Witte1,2, N Victor2, MW Buchler1,3 and 
HP Knaebel*1,3
Address: 1Study Center of the German Surgical Society (SDGC), University of Heidelberg, Germany, 2Institute of Medical Biometrics and 
Informatics (IMBI), University of Heidelberg, Germany and 3Department of General-, Visceral-, Trauma Surgery, University of Heidelberg, 
Germany
Email: CM Seiler - christoph_seiler@med.uni-heidelberg.de; BE Fröhlich - boris_froehlich@med.uni-heidelberg.de; 
JA Veit - johannes_veit@med.uni-heidelberg.de; E Gazyakan - gazyakan@bgu-ludwigshafen.de; MN Wente - moritz_wente@med.uni-
heidelberg.de; C Wollermann - knauer@imbi.uni-heidelberg.de; A Deckert - deckert@imbi.uni-heidelberg.de; S Witte - witte@imbi.uni-
heidelberg.de; N Victor - victor@imbi.uni-heidelberg.de; MW Buchler - markus_buechler@med.uni-heidelberg.de; HP Knaebel* - hanns-
peter_knaebel@med.uni-heidelberg.de
* Corresponding author    
Abstract
Background: Annually, more than 90000 surgical procedures of the thyroid gland are performed
in Germany. Strategies aimed at reducing the duration of the surgical procedure are relevant to
patients and the health care system especially in the context of reducing costs. However, new
techniques for quick and safe hemostasis have to be tested in clinically relevance randomized
controlled trials before a general recommendation can be given. The current standard for occlusion
of blood vessels in thyroid surgery is ligatures. Vascular clips may be a safe alternative but have not
been investigated in a large RCT.
Methods/design: CLIVIT (Clips versus Ligatures in Thyroid Surgery) is an investigator initiated,
multicenter, patient-blinded, two-group parallel relevance randomized controlled trial designed by
the Study Center of the German Surgical Society. Patients scheduled for elective resection of at
least two third of the gland for benign thyroid disease are eligible for participation. After surgical
exploration patients are randomized intraoperatively into either the conventional ligature group,
or into the clip group. The primary objective is to test for a relevant reduction in operating time
(at least 15 min) when using the clip technique. Since April 2004, 121 of the totally required 420
patients were randomized in five centers.
Discussion: As in all trials the different forms of bias have to be considered, and as in this case, a
surgical trial, the role of surgical expertise plays a key role, and will be documented and analyzed
separately. This is the first randomized controlled multicenter relevance trial to compare different
vessel occlusion techniques in thyroid surgery with adequate power and other detailed information
about the design as well as framework. If significant, the results might be generalized and may
change the current surgical practice.
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Background
Annually, a total of more than 90.000 surgical thyroid
procedures are performed in surgical departments
throughout Germany [1]. The prevalence of the endemic
goiter in the adult population ranges between 20% and
30% in this iodine deficiency area [2]. Today, thyroid sur-
gery is a highly standardized procedure with low morbid-
ity and mortality. Several techniques of occluding vessels,
besides the classic ligatures, are currently available. The
clamp and tie technique is still the most frequently used
standard, although it requires several steps which in addi-
tion are time-consuming. An alternative technique is the
application of vascular clips that have proven to be fast,
effective and safe for achieving hemostasis in different sur-
gical areas [3,4]. In thyroid surgery, however, no rand-
omized controlled trial (RCT) has so far been performed
comparing vascular clips with the conventional clamp
and tie technique. Only ultrasonically activated shears
were tested against the conventional technique in a RCT
and found to be a suitable device in total thyroidectomies
and lobectomies [5,6]. However, Voutilainen et al. (2000)
stated that the advantage of the ultrasonically activated
shears in thyroid surgery is probably of less importance
for surgeons who achieve good results with vascular clips.
Aim of the study
Besides achieving the best surgical outcome (low morbid-
ity and mortality as well as absence of recurrence), operat-
ing time is an important factor for thyroid surgeons [7-
10]). A reduction in operating time is not only beneficial
for the patients, due to reduction of the risk associated
with the time of general anaesthesia, but also for the
health care system, because every minute of operating
time saves approximately 8–11 € [6,11]. Hence, there is a
large interest in performing surgery that is not only safe,
but also fast and cost effective. Especially in centers with
more than 60 – 100 thyroidectomies annually, the intro-
duction of methods which potentially may reduce operat-
ing time, will significantly increase the level of
effectiveness [12].
Need for this study
To date, no clear scientific recommendation exists in
regard to the available blood vessel ligation techniques in
thyroid surgery. A systematic review comparing different
blood vessel ligation techniques has not yet been per-
formed. The literature on this topic shows several deficits
thus reducing its internal and external validity. Main
problems are underpowered sample sizes [6,13], missing
data in regard to the surgical technique [5], lack of stand-
ardization of the various surgical techniques [5] and of
homogeneity of the used study designs [6].
Therefore a randomized controlled multicenter, patient-
blinded, two-group parallel relevance study under stand-
ardized conditions is required in order to achieve high
internal as well as external validity. This would allow the
results to be generalized for thyroid surgery and also may
have implications for other surgical settings. This study is
one of the first studies designed and organized by the
Study Center of the German Surgical Society (SDGC).
Besides investigating the primary hypothesis, this study
was also started with the aim of developing a nationwide
structure for randomized trials using a common and sur-
gical relevant procedure [14].
This article describes the design and current status of the
CLIVIT trial to publicly lay open the assumptions that
have been made at the beginning of the trial. According to
Chan et al. (2004) it is not uncommon that primary end-
points are changed during the conduction of a clinical
trial leading to substantial protocol violations and thereby
misleading the medical community [15]. A protocol pub-
lication might help to prevent this. Surgical trials are still
inferior in their internal validity compared to pharmaco-
logical studies [16]. Especially the clear description of
concealed allocation sequences, interventions and assess-
ment of surgeons' experience, safety issues and outcome
evaluation are of interest.
Methods/design
Trial population
The major eligibility criteria is a benign disease of the thy-
roid gland – except Graves disease – scheduled for elective
(a) hemithyroidectomy and subtotal resection of the
other side, (b) near total or (c) total thyroidectomy.
Malignant diseases of the thyroid gland, hyperparathy-
roidism, re-operations and Graves disease were excluded
from the study for they do have a higher risk for damage
of the recurrent laryngeal nerve in surgery and/or they are
not standard operations in smaller hospitals [17].
Detailed inclusion and exclusion criteria are specified in
Table 1. Patients are screened consecutively for eligibility
in all participating centers after approval of the study pro-
tocol by the local ethics committee. A contract has been
signed by the SDGC and the participating hospitals for
correct conduction of the trial according to Good Clinical
Practice. All participating surgeons performing the inter-
ventions have been instructed by detailed manuals and
the clips as well as their reusable applicators are provided.
Clinical sites and safety aspects
Sites are selected according to their experience in thyroid
surgery and willingness to adhere to the clinical trial pro-
tocol. The surgical expertise of each participating surgeon
is documented and taken into account during the analysis
of the trial data. The participating centers are listed at the
end of this paper.Trials 2006, 7:27 http://www.trialsjournal.com/content/7/1/27
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For safety reasons concomitant medication and medical
history are checked prior to operation. Patients at higher
risk for complications (e.g. bleeding disorder, history of
neck operation) are excluded from the study. All serious
adverse events (SAE) will be reported to the principal
investigator and the leading ethics committee. For the
safety analysis the incidence of adverse events (AE) and
SAE will be analyzed. Patients may withdraw from the
study at any time either at their own request or at the
request of the principal investigator.
Interventions
A standardized surgical approach to the thyroid gland will
be performed in both groups:
The skin is cut with a conventional scalpel (Kocher's inci-
sion). Subcutaneous layer and platysma are cut with the
electric cautery. After splitting cervical fascia, the infrahy-
oideal muscles are set aside with retractors. Cervical mus-
cles should be cut only exceptionally. The thyroid gland is
then completely exposed in order to define the extent of
the required surgical procedure. If the findings are in
accordance with the trial inclusion criteria, randomiza-
tion is performed. Regardless of the randomization result
the procedure always starts with preparation and ligation
of the upper pole vessels on the side of the hemithyroid-
ectomy (Novafil® 3-0 or equivalent suture material). At the
moment of dividing the upper pole vessels the time is
taken and the operation then continues according to the
regulations of the specified randomization group.
Clip Group
In the Clip Group each vessel will be occluded by applica-
tion of one medium size clip close to the thyroid and two
medium-size clips distal to the thyroid using the BBD-Aes-
culap Challenger® clip applicator (BBD-Aesculap, Tuttlin-
gen, Germany).
Ligature Group
In the ligature group each vessel will be occluded by man-
ual ligature (Vicryl® 3-0 or equivalent suture material)
using the square-knot technique and divided with scissors
after ligation.
Both groups
The bipolar diathermy as an additional tool is allowed in
both study groups. Time measurement stops as soon as
the thyroid gland is removed. Following the resection, the
capsule is sutured with an inverted continuous suture
technique (PDS® 4-0 or equivalent suture material). After
hemostasis uni- or bilateral drains (10 French sized
Redons-drains) are placed into the resection area. Cervical
muscles in the mid-line and platysma are adapted with
conventional interrupted sutures. The operation is com-
pleted with intracutaneous sutures and sterile wound
dressing.
Objectives and outcomes
The primary objective of this study is to test whether there
is a relevant reduction in operating time (>15 min), using
the clip vessel occluding technique versus the conven-
tional clamp-tie. Secondary objectives are divided into
surgical and non-surgical categories. In the surgical cate-
gory there are the following points: total duration of oper-
ation (skin incision until suture), weight of specimen,
amount of postoperative bleeding, frequency of reopera-
tion due to bleeding, recurrent laryngeal nerve paralysis
(temporary or irreversible – pre- and postoperative assess-
ment of vocal cord function by ENT-specialist), wound
infection rate and rate of impaired parathyroid gland
Table 1: CLIVIT trial: study inclusion and exclusion criteria
INCLUSION CRITERIA EXCLUSION CRITERIA
At study enrollment:
• Age equal or greater than 18 years
• Expected survival time more than 12 months
• Patients with benign diseases of the thyroid gland scheduled for 
elective surgery
• Euthyroid metabolism (normal level of TSH or T3/T4)
• Normal function of the vocal cords
• Informed consent
• Malignant disease or highly suspicion for malignancy (clinical and 
imaging evidence)
• Nerve palsy
• Graves' Disease
• Coagulopathy
• Current immunosuppressive therapy
• Chemotherapy within 2 weeks before operation
• Radiotherapy completed no longer than 8 weeks before operation
• Severe psychiatric or neurologic disease
• Drug- and/or alcohol-abuse
• Participation in another intervention-trial with interference of 
intervention and outcome
• Inability to follow the instructions given by the investigator or the 
telephone interviewer
• Lack of compliance
At the end of surgical exploration:
• Suitable for at least 2/3 resection of the thyroidTrials 2006, 7:27 http://www.trialsjournal.com/content/7/1/27
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function. The non-surgical category consists of duration of
postoperative hospital stay. To assess the relevance of the
chosen endpoints, the following ten aspects have to be
ranked from "most important" to "least important" by
patients and surgeons (only once): Intraoperative compli-
cations, postoperative complications, length of hospital
stay, voice function, dysphagia, death, postoperative pain,
postoperative fatigue, convalescence of complete physical
maximum resilience and cosmetic result [18].
Sample size
A relevant difference between the two operations is
defined as greater than 15 minutes. The expected differ-
ence is 20 minutes. Analysis of retrospective data showed
a standard deviation of about 27 minutes for the whole
operation. For the primary endpoint a percentage of 70%
of the whole operation time is assumed. If this percentage
were exactly 70% for every operation, standard deviation
for the primary endpoint would be 0.7*27 min = 18.9
minutes. Since this relation will probably not be so strict,
the standard deviation for the primary endpoint is esti-
mated to be higher. Thus, a standard deviation of 20 min-
utes is assumed. The α level is set to 0.05; therefore, 200
patients per group are required to obtain a power of 80%
(β = 0.2) using a simple one-sided t-test for two groups
with a shifted null-hypothesis. Due to the fact that no
interaction is expected regarding surgeon experience and
treatment group, the sample size calculation is also valid
for the ANOVA model of the primary analysis. In order to
incorporate an expected early dropout rate of 5%, a total
of 420 patients is required.
Randomization and blinding
A block randomization list with alternating block sizes
was generated by the Institute for Medical Biometrics and
Informatics (IMBI) using SAS (SAS Version 8.2, SAS Insti-
tute Inc., Cary, USA) for each center. The randomization
code is stored at the IMBI and is not accessible to any clin-
ical investigator. Until opening the sealed envelopes the
allocation sequence is concealed in envelopes. If the indi-
cation for a trial randomization is not given after explora-
tion, the sealed envelope will be used for the next patient.
Prerequisite for this is an intact seal on the opaque rand-
omization envelope. Envelopes are used because any elec-
tronic or telephone systems would have substantially
increased the costs of the trial without any funding avail-
able to cover these. Furthermore, easily accessible compu-
ter systems are not available in all surgical theatres of the
participating centers.
Randomization and time measurement is performed by
an independent member of the clinical site (study nurse
or anesthesiologist) who is not involved in the surgical
procedure.
After randomization the assigned group result is con-
cealed. Subsequent investigations are performed by
blinded study nurses or blinded investigators in order to
assure unbiased assessment of endpoints when possible.
Statistical analysis
The participating centers collect the data and send the case
report forms to the SDGC in Heidelberg. Double data
entry is done and queries are generated for statistical mon-
itoring. The analysis will be performed by the IMBI in
cooperation with the SDGC using an analysis plan.
A confirmatory analysis of variance (ANOVA) is planned
for the primary endpoint based on the intention-to-treat
(ITT) principle to test at first the hypothesis H0: μlig-μclip≤0
and in case of statistical significance the hypothesis H0:
μlig-μclip≤15, with the expected operating times μlig and
μclip, each on the α-level of 5%. The a priori ordered
hypotheses hold the overall α-level of 5%. A randomized
patient belongs to the ITT population after the upper ves-
sels have been cut. The fixed factors of this ANOVA will be
vessel occlusion technique, center and surgeons experi-
ences. The relation between applied technique and dura-
tion of procedure is severely influenced by the surgeon's
expertise. Therefore experience is categorized into two
groups: surgeons having performed ≥ 50 or <50 thyroid
operations. Since there are so far no publications on this
topic, the cut-off value of 50 operations was chosen, based
on the results of an internal pilot study of the University
of Heidelberg on learning curves of surgeons,.
Even if neither superiority nor relevance can be shown sta-
tistically, the exploratory interpretation of the narrow
two-sided confidence intervals (expected width <10 min-
utes) can be used to compare the difference in operating
time. Some sensitivity analyses are planned, using a linear
mixed model as well as using the per-protocol population
which consists of all patients of the ITT population with-
out major protocol violations.
Secondary endpoints will be analyzed and characterized
using descriptive statistics. An interim analysis is not
planned.
Trial organization, quality control, registration and ethical 
aspects
The trial was designed at the Study Center of the German
Surgical Society (Studienzentrum der Deutschen Gesells-
chaft für Chirurgie, SDGC) in cooperation with the Insti-
tute of Medical Biometrics and Informatics (IMBI) at the
University of Heidelberg, Medical School. Trial monitor-
ing is done by an independent monitor of the SDGC. The
trial is performed according to the Declaration of Helsinki
in its current German version and the Good Clinical Prac-
tice (GCP). Before trial start the independent ethic com-Trials 2006, 7:27 http://www.trialsjournal.com/content/7/1/27
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mittee gave a positive vote on January 7th, 2004. All
participants will be informed about the trial and the writ-
ten informed consent must be signed before randomiza-
tion. The trial was registered in December 2003 at the
International Standard Randomized Controlled Trial
Number Registration (ISRCTN96901396).
Two Amendments were accepted before this publication
by the ethical committees: in the first amendment two
additional secondary objectives (total time of the proce-
dure, weight of specimen) were added. This was done in
order to improve evaluation of the primary objective
'resection time' which is calculated by measuring the time
between the completion of ligation of the upper pole ves-
sels and the time of removal of the complete specimen.
The second amendment was introduced to expand the
inclusion criteria in regard to the type of operation. Until
then, only hemi-thyroidectomies in combination with
subtotal thyroid resection of the other side were included
into the trial. Since this operation is not the only standard
surgical procedure in goiter surgery in Germany, complete
thyroidectomy and near-total thyroidectomy were added.
The surgical details of these techniques are not in conflict
with the objectives of the study. By this second amend-
ment a shorter recruitment period is expected.
Current status and duration of the trial
Up to now six centers are initiated and 155 patients, of the
400 needed, were randomized by five centers (status July
5th, 2006, details see acknowledgements). The first patient
was randomized on March 5th, 2004. The expected recruit-
ment period will last until the end of 2008.
Discussion
The evaluation of optimal surgical therapeutic options
and procedures should be performed according to the best
current knowledge. Due to the principles of Evidence-
based Medicine (EbM), the randomized controlled trial
(RCT) is assumed to be the gold standard in evaluating
different medical methods and procedures. Even in RCTs,
though, the risk of bias should not be underestimated. In
surgical trials a double blinded trial design is difficult to
establish; therefore, the patient selection, power, rand-
omization, surgeon's skill, data assessment and documen-
tation of outcome measures and statistical analyses are
important design issues and susceptible to the different
forms of bias. Hence, all these issues are specified in the
trial protocol a priori.
Selection bias. To minimize the selection bias all patients
scheduled for thyroid surgery are screened consecutively
in all participation sites. Moreover, neither patient age nor
the size of the goiter is an exclusion criterion. Screening
lists and case report files are monitored by independent
investigators from the SDGC to ensure correct patient
recruitment and meticulous documentation.
Randomization bias. Randomization is done in a block
randomization system with alternating block sizes to
avoid positive prediction of the last procedures in each
block. The calculated randomization sequence is sealed at
the IMBI for each participating center. Envelopes are non-
transparent and cannot be resealed after opening. After
exploration of the thyroid gland and affirmation of the
indication an intra-operative randomization is per-
formed. The unclosed randomization sheet is sent via fax
to the IMBI.
Surgeon's expertise bias. Another source of bias is the sur-
geon's expertise. Most often new surgical techniques or
methods are introduced by the most experienced sur-
geons. To minimize this source of bias stratification for
surgeon's skill is made, and measured data will be ana-
lyzed by analysis of variance in regard to surgeon's skill,
center and vessel occlusion technique. Due to this analysis
of variance, bias of center effects and surgeon's skill
should be reduced. Possible complications such as bleed-
ing, re-operation due to bleeding, recurrent palsy or
impaired function of parathyroid glands are assessed by
blinded study nurses or investigators. Re-operation, recur-
rent palsy and impaired function of parathyroid glands
are obvious events that can not be diminished by the
responsible surgeon.
Prevention of non-conclusive results. Recent reports com-
paring different methods of hemostasis in thyroidecto-
mies were underpowered or not designed as RCTs. In the
calculation of the sample size of 420 patients, a post ran-
domization drop out of 10 patients in each allocation arm
and additional 40 patients for each secondary endpoint
for 'lost to follow up' are included. Thus, the calculated
sample size is large enough to draw definite conclusions.
The interpretation of the hypothesis has a high statistical
power: a significant result of this relevance test is equiva-
lent to a time difference of at least 15 minutes [19].
Publication bias. One important tool to avoid bias in clin-
ical trials is the international registration and publication
of trial protocols. CLIVIT was registered in 2003 before the
subsequent requirement of the International Committee
of Medical Journal Editors were published [20].
In conclusion, this is the first randomized controlled mul-
ticenter relevance trial comparing different vessel occlu-
sion techniques in thyroid surgery with adequate power
and sufficient detailed information about the design as
well as framework. If significant, the results might be gen-
eralized and may change the current surgical practice.Publish with BioMed Central    and   every 
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